Package encapsulant relief feature
    41.
    发明授权
    Package encapsulant relief feature 有权
    封装封装消除功能

    公开(公告)号:US09281256B2

    公开(公告)日:2016-03-08

    申请号:US14035999

    申请日:2013-09-25

    申请人: Min Ding Tim V. Pham

    发明人: Min Ding Tim V. Pham

    摘要: A microelectronic device package including a package substrate, microelectronic component disposed on a first surface of a first portion of the substrate, and encapsulant material surrounding the microelectronic electronic component. An exposed surface of the first portion of the substrate is exposed through an opening in a first major surface of the encapsulant material. The exposed surface of the first portion has an edge. Encapsulant material is adjacent to the edge at the first major surface. The exposed surface is opposite the first surface. A stress relief feature located in one of the first major surface or a second major surface of the encapsulant material. The second major surface is opposite the first major surface. The stress relief feature reduces an amount of the encapsulant material and is 1 mm or less of a plane of the edge of the exposed surface. The plane is generally perpendicular to the exposed surface.

    摘要翻译: 一种微电子器件封装,包括封装衬底,设置在衬底的第一部分的第一表面上的微电子部件和围绕微电子电子部件的密封材料。 衬底的第一部分的暴露表面通过密封剂材料的第一主表面中的开口露出。 第一部分的暴露表面具有边缘。 密封材料与第一主表面的边缘相邻。 暴露的表面与第一表面相对。 应力消除特征位于密封剂材料的第一主表面或第二主表面之一中。 第二主表面与第一主表面相对。 应力释放特征减少了密封剂材料的量,并且是暴露表面的边缘的平面的1mm或更小。 平面大致垂直于暴露的表面。

    System and Method for Determining Application Dependency Paths in a Data Center
    44.
    发明申请
    System and Method for Determining Application Dependency Paths in a Data Center 有权
    确定数据中心应用依赖路径的系统和方法

    公开(公告)号:US20110276682A1

    公开(公告)日:2011-11-10

    申请号:US13100805

    申请日:2011-05-04

    IPC分类号: G06F15/173

    摘要: A method and a system are disclosed for determining application dependency paths in a data center. The method and the system captures application traffic volume data on the servers with switches and monitoring agents; generates an application traffic matrix of all the components of the applications based on the application traffic volume data; estimates the number of the applications in the data center from the traffic matrix with a Rank Estimation via Singular Value Decomposition or Power Factorization Residue Errors process; and decomposes the traffic matrix into a first matrix and a second matrix with a non-negative matrix factorization process using the estimated number of applications. The first matrix represents a set of the components belonging to each of the applications and the second matrix represents the amount of traffic generated by each application over time. Any noise in the first and second matrices is removed with a concurrent volumes ratios based correlation process.

    摘要翻译: 公开了一种用于确定数据中心中的应用依赖路径的方法和系统。 该方法和系统使用交换机和监控代理在服务器上捕获应用程序流量数据; 基于应用业务量数据生成应用的所有组件的应用业务矩阵; 通过奇异值分解或功率因子分解残差误差进行等级估计从业务矩阵估计数据中心中的应用数量; 并且使用估计的应用数量将业务矩阵分解为第一矩阵和具有非负矩阵分解过程的第二矩阵。 第一矩阵表示属于每个应用的组件的集合,第二矩阵表示每个应用随时间生成的流量。 第一和第二矩阵中的任何噪声均以基于并发卷比的相关过程被去除。

    Antenna Assembly
    45.
    发明申请
    Antenna Assembly 审中-公开
    天线装配

    公开(公告)号:US20110102293A1

    公开(公告)日:2011-05-05

    申请号:US12937083

    申请日:2008-04-10

    IPC分类号: H01Q3/24

    摘要: An antenna module that includes two directional antennae arranged in a back-to-back manner, and a converter. The converter realizes conversion between an omnidirectional antenna mode and a directional antenna mode by switching on two directional antennae simultaneously or by switching on one of the directional antennas. Alternatively, the antenna module includes a horizontal polarization antenna, a vertical polarization antenna and a converter, where the converter provides the conversion between the horizontal polarization antenna mode and the vertical polarization antenna mode by switching on the horizontal polarization antenna or the vertical polarization antenna.

    摘要翻译: 一种天线模块,包括以背对背方式布置的两个定向天线,以及转换器。 该转换器通过同时接通两个定向天线或通过接通定向天线之一来实现全向天线模式和定向天线模式之间的转换。 或者,天线模块包括水平极化天线,垂直极化天线和转换器,其中转换器通过开启水平极化天线或垂直极化天线来提供水平极化天线模式和垂直极化天线模式之间的转换。

    Systems and methods for application dependency discovery
    46.
    发明授权
    Systems and methods for application dependency discovery 有权
    用于应用程序依赖关系发现的系统和方法

    公开(公告)号:US08725871B2

    公开(公告)日:2014-05-13

    申请号:US13284350

    申请日:2011-10-28

    摘要: Systems and methods for discovering a set of applications that run on a network are disclosed. In accordance with one method, aggregate traffic volumes are determined for pairs of nodes on the network over a plurality of time intervals. The method further includes building a traffic matrix denoting each of the pairs of nodes and denoting respective aggregate traffic volume histories of each of the pairs of nodes that are based on the determined traffic volumes. In addition, the traffic matrix is formulated as a combination of bases vectors that model the set of applications. The bases vectors are determined by applying a covariance matrix adaptation evolutionary strategy based on the traffic matrix. An indication of the set of applications based on the bases vectors is output.

    摘要翻译: 公开了用于发现在网络上运行的一组应用的系统和方法。 根据一种方法,在多个时间间隔上为网络上的节点对确定聚合业务量。 该方法还包括构建表示每对节点的业务矩阵并且表示基于所确定的业务量的每对节点对应的聚合业务量历史。 另外,业务矩阵被形成为对应用集合建模的基本向量的组合。 通过应用基于业务矩阵的协方差矩阵适应进化策略来确定基本向量。 输出基于基本向量的应用集合的指示。

    PHARMACEUTICAL COMPOSITIONS AND METHODS FOR STABILIZING THE SAME
    47.
    发明申请
    PHARMACEUTICAL COMPOSITIONS AND METHODS FOR STABILIZING THE SAME 审中-公开
    药物组合物及其稳定化方法

    公开(公告)号:US20120322836A1

    公开(公告)日:2012-12-20

    申请号:US13600083

    申请日:2012-08-30

    摘要: Pharmaceutical compositions, and a method of stabilizing pharmaceutical compositions having clevidipine, or any pharmaceutically acceptable salt thereof, as the active ingredient is described. The method includes the slowing down or inhibiting of the oxidation pathway of clevidipine. This can be accomplished by reducing the amount the pharmaceutical composition is exposed to oxygen and/or light during the manufacturing and storing processes. According to this method, oxygen must be removed or replaced, or light must be sufficiently blocked such that light energy cannot reach the active ingredient of the composition, or is reduced to a level that the light-induced oxidation reaction converting clevidipine to H324/78 is minimized, such that the total detectable level of H324/78 in a given composition sample does not exceed about 0.2% on a weight-by-weight basis, or the ratio of clevidipine to H324/78 is equal to or greater than about 450 to 1 on a weight-to-weight basis.

    摘要翻译: 描述了药物组合物和稳定具有氯维地平的药物组合物或其任何药学上可接受的盐作为活性成分的方法。 该方法包括减缓或抑制氯维地平的氧化途径。 这可以通过在制造和储存过程中减少药物组合物暴露于氧和/或光的量来实现。 根据该方法,必须除去或更换氧气,或者必须充分阻挡光,使得光能不能达到组合物的活性成分,或者降低到光诱导的氧化反应将氯维地平转化为H324 / 78 被最小化,使得给定组合物样品中H324 / 78的总可检测水平以重量计不超过约0.2%,或者氯维地平与H324 / 78的比例等于或大于约450 至1,以重量为基准。